These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18370844)

  • 1. Pharmacogenomics of metabolic effects of rosiglitazone.
    Seda O; Sedová L; Oliyarnyk O; Kazdová L; Krenová D; Corbeil G; Hamet P; Tremblay J; Kren V
    Pharmacogenomics; 2008 Feb; 9(2):141-55. PubMed ID: 18370844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain.
    Seda O; Kazdova L; Krenova D; Kren V
    Physiol Genomics; 2003 Jan; 12(2):73-8. PubMed ID: 12429866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone improves insulin resistance, lipid profile and promotes adiposity in a genetic model of metabolic syndrome X.
    Seda O; Kazdová L; Krenová D; Kren V
    Folia Biol (Praha); 2002; 48(6):237-41. PubMed ID: 12512799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary sardine protein lowers insulin resistance, leptin and TNF-α and beneficially affects adipose tissue oxidative stress in rats with fructose-induced metabolic syndrome.
    Madani Z; Louchami K; Sener A; Malaisse WJ; Ait Yahia D
    Int J Mol Med; 2012 Feb; 29(2):311-8. PubMed ID: 22085913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
    Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
    J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
    Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
    Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice.
    Yang KJ; Noh JR; Kim YH; Gang GT; Hwang JH; Yang SJ; Yeom YI; Lee CH
    Life Sci; 2010 Sep; 87(13-14):405-10. PubMed ID: 20723549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
    Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
    Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic characterization of insulin resistance syndrome feature loci in three brown Norway-derived congenic strains.
    Seda O; Sedová L; Kazdová L; Krenová D; Kren V
    Folia Biol (Praha); 2002; 48(3):81-8. PubMed ID: 12118727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
    Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
    Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between adipose phosphoenolpyruvate carboxykinase and occurrence and reversion of insulin resistance].
    Zhao WH; Xiao JZ; Yang WY; Wang N; Wang X; Chen XP; Bu S
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3074-8. PubMed ID: 16324411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E941-9. PubMed ID: 14749206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain induced by high-fat feeding involves increased liver oxidative stress.
    Milagro FI; Campión J; Martínez JA
    Obesity (Silver Spring); 2006 Jul; 14(7):1118-23. PubMed ID: 16899792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High fat and highly thermolyzed fat diets promote insulin resistance and increase DNA damage in rats.
    de Assis AM; Rieger DK; Longoni A; Battu C; Raymundi S; da Rocha RF; Andreazza AC; Farina M; Rotta LN; Gottfried C; Gonçalves CA; Moreira JC; Perry ML
    Exp Biol Med (Maywood); 2009 Nov; 234(11):1296-304. PubMed ID: 19855071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.